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Background: The protozoan Toxoplasma gondii is the causative agent of toxoplasmosis, with complications varying
from mental disease to death. While human infection can occur via ingestion of tissue cysts from infected meat,
most human infection comes from oocysts. Cats are the only definitive host, and thus shedding of oocysts by cats
provides the ultimate source of toxoplasmosis.
Methods: While most studies in the area use seroprevalence to monitor Toxoplasma incidence in cat populations,
this provides only a history of infection. This study used PCR detection of oocysts from cat feces to more accurately
estimate the numbers of cats producing oocysts and thus posing an active health risk. DNA sequencing was use to
confirm the identity of the PCR products.
Results: Of the 49 cats tested, 9 yielded PCR products of the expected size. Six of the nine were determined by
sequence analysis to be false positives, while three products were true positives. Overall, 6% of cats examined were
found to be actively shedding oocysts.
Conclusions: The incidence of oocyst shedding in the cat population studied was significantly higher than
expected and higher than found in most cat populations world-wide. Of equal importance, the primers tested were
shown to produce PCR products of multiple sizes and non-target products of expected size. We detected false
positives at a higher rate than true positives, emphasizing the need for confirmatory analysis. Further research may
produce better protocols for Toxoplasma detection from cat fecal samples.
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Toxoplasmosis, caused by the protozoan Toxoplasma
gondii, can lead to encephalitis, retinitis, and myocarditis
[1,2]. Among immuno-compromised individuals, toxo-
plasmosis is a leading cause of hospitalization and death
[3]. Congenital toxoplasmosis affects an estimated 5000
newborns each year in the United States [4], resulting in
prematurity, mental retardation, and ocular disease [5].
Acute maternal infection can also result in fetal loss or
neonate death [5,6]. This is particularly concerning given
that 85-89% of childbearing age women have no immun-
ity to T. gondii [7], and are thus at risk of developing an
acute infection if exposed to the parasite.
Chronic infection occurs in approximately 22.5% of
the US population [7]. The latent infection appears to* Correspondence: lillyel10@vmi.edu
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distribution, and reproduction in any mediumpose no direct physical health risks, but it has been asso-
ciated with increased rates of disturbing behavior, in-
cluding homicide [8], suicide and other self-directed
violence [9], as well as increased incidence of schizo-
phrenia and other neuropsychiatric diseases [10].
Primary routes of acute human T. gondii infection in-
clude ingestion of tissue cysts in undercooked, contami-
nated meat, congenital infection through the placenta,
and ingestion of oocysts from soil, water, or cat litter
[7,11]. Oocysts are produced by T. gondii only through
sexual reproduction in its definitive host, the cat [11-13].
Oocysts are shed in cat feces and can remain viable in
soil and water samples for months to years [14]. Individ-
uals with occupations requiring contact with soil in envi-
ronments frequented by cats are significantly more likely
to contract toxoplasmosis [7]. However, the more signifi-
cant risk factor is contact with cats and cat litter.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Table 1 Primers used for PCR detection of Toxoplasma
gondii oocysts in fecal samples









Expected product size 529 bp 129 bp
Reference [13,30,31] [29]
Sequences of primers used in this study to detect Toxoplasma gondii.
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but having three or more kittens makes an individual
over 70 times more likely to become infected with T.
gondii [4]. While acute infection can be fatal to young
kittens [12], cats may be asymptomatic [11], increasing
the likelihood of accidental infection.
Toxoplasma gondii is ubiquitous in Virginia. Anti-
bodies to T. gondii were present in the sera of 27% of
tested lambs [15], 20% of tested dogs [16], and 27% of
tested cats [17]. However, documentation of T. gondii
antibodies could indicate prior exposure or a latent in-
fection in which T. gondii is present only in tissue cysts
[18]. In food animals such as lambs, tissue cysts repre-
sent a potential health risk for humans through meat
consumption [15], but they are unlikely to pose a risk in
a non-food animal like the cat. In cats, danger of infec-
tion exists only when the animal is actively shedding
oocysts [11].
The majority of oocysts are produced shortly after the
initial acquisition of the parasite, peaking within a
month of initial infection [11,12]. Oocyte shedding gen-
erally lasts no more than 21 days [11,19], although it
may recur with immunosuppression [20]. In comparative
studies of blood serum and fecal assays, 0% [21-25], 3%
[26], 4% [27], and 6% [28] of seropositive cats were
found to have oocyte-contaminated feces. Thus, while
serological testing may be applicable for determining
parasite exposure, it is likely to vastly overestimate hu-
man health risk from cats.
Methods for determining oocyte presence in fecal
samples include microscopy, mouse bioassay, and PCR
[11,13]. Microscopy is time consuming and requires spe-
cialized training to visually identify T. gondii oocysts
[13]. In addition, cyst-forming organisms with similar
morphology must be differentiated with subsequent tests
[11,19]. Mouse bioassay is more sensitive than micros-
copy [28], but requires the use of live mice and amplifies
T. gondii, posing a biohazard. PCR is the most time-
efficient of the three, requires only common molecular
biology experience, easily differentiates T. gondii from
other cyst forming eukaryotic parasites, and is highly
sensitive [13,27].
In this study, two previously developed sets of PCR
primers [13,29-31] were used in combination with se-
quence confirmation to determine oocyte presence in
cat feces collected throughout Rockbridge County, VA.
Methods
Fecal samples
Sixty unique fecal samples were collected from both pet
and stray cats in Rockbridge County, VA. Domestic en-
vironmental conditions of the pet cats were defined as
“indoor only,” or “both indoor and outdoor.” Cats living
outside only were categorized as “stray.”Coprologic diagnosis by PCR
DNA was extracted from each sample using the
QIAamp® DNA Stool Mini Kit (Qiagen), with modifica-
tions to the extraction protocol as previously described
[13]. Two sets of T. gondii specific primers (Table 1)
were used in separate PCR reactions for every sample.
Amplification followed the methodology of the reference
paper. Universal bacterial 16S rRNA gene primers 27F
and 1492R were used as positive controls to ensure that
DNA extracts contained amplifiable DNA and were free
of PCR inhibitors.
Post amplification analysis
PCR products were separated on agarose gels. When
multiple bands were observed, bands of appropriate size
for the primer set used were excised and extracted using
QIAquick® Gel Extraction. The purified products were
sent for commercial DNA sequencing. The chromato-
graphs were analyzed by hand for accuracy and the
resulting sequences were subjected to nucleotide BLAST
analysis [32].
Results
Positive control reactions amplified bacterial DNA from
49 of the fecal samples; 48% of which were from stray
cats; 33% were from strictly indoor pets; and 11% from
cats with both indoor and outdoor access. Gel electro-
phoresis showed that many of the PCR products pro-
duced with both primer sets, (up to 8–10 per sample),
were not of the appropriate size, indicating non-specific
amplification. Nine of the samples (18%) yielded bands
of predicted size, which were excised and sequenced.
There was a high incidence of false positives: 6 of the 9
bands of appropriate size produced sequences identified
as common fecal bacteria. Three samples, (from 1 stray
and 2 indoor/outdoor pets), yielded sequences with high
identity to known Toxoplasma gondii isolates, and were
identified as positive for T. gondii oocytes. Thus, the in-
cidence of oocyte shedding was determined to be 6%
(3/49). One of the positive samples yielded positive re-
sults with both primer sets; the remaining two produced
T. gondii products only with the primers developed by
Costa et al. [29].
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Twelve recent studies provided thirteen values for the
percentage of cat fecal samples testing positive for Toxo-
plasma gondii oocysts (Table 2). For each study, a χ2 test
was used to determine whether there were a statistically
different number of positive fecal samples in Rockbridge
County, VA, than would have been expected had the
percent positive matched the reference study. The per-
cent positive in this study (6%) was significantly higher
than expected when compared with 10 of the samples,
comparable with 2, and less than expected when com-
pared with the feral cat population in Ethiopia (when
assayed by mouse bioassay, Table 2).
Discussion
The prevalence of Toxoplasma gondii oocyst shedding
among the cat population in Rockbridge County, VA,
was significantly greater than 10 of the 12 reference pop-
ulations (Table 2). The only sample statistically higher
than the current study was a population of feral cats
from Ethiopia, where, 16% of cats tested copropositive
by PCR, 22% tested copropositive by mouse bioassay,
and 92% of cats tested seropositive for T. gondii anti-
bodies, which is far above the world average of 30-40%
seropositive cats [11].
T. gondii in Rockbridge County warrants further study
to confirm the high prevalence and to determine poten-
tial causes and human impacts. In addition to studying
cats, it would be prudent to sample soil and water as
well, given that environmental T. gondii concentrations
are higher when infected cats are present [37,38].
Of equal concern, both primer sets published as spe-
cific to and diagnostic for Toxoplasma gondii yielded a
substantial number of false positives. Fifty percent ofTable 2 Comparison of the current study (6% positive) with p
Location Cat type Method Fecal positives (
China Stray Mouse bioassay 0%
China Stray Mouse bioassay 0%
Egypt Stray Mouse bioassay 0%
Spain Stray and pet Microscopy 0%
Colombia Stray Mouse bioassay 0%
Europe Stray and pet Microscopy 0.11%
Switzerland Stray and pet PCR 0.30%
United States (CA) Stray and pet Microscopy 0.90%
Canada (PEI) Stray Microscopy 1.30%
Finland Stray Microscopy/PCR 1.50%
Ethiopiaa Stray Microscopy 5.50%
Italy Stray PCR 16%
Ethiopiaa Stray Mouse bioassay 22.20%
aThe same cats were tested by both microscopy and mouse bioassay, with greater
Comparison between current data and other measures of oocyst shedding in cat fePCR products of relevant size were shown to be derived
from fecal bacteria upon full sequence analysis. Addition-
ally, multiple bands of irrelevant size were also produced,
although PCR parameters were as described in the refer-
ence studies [13,29,31]. The false positives emphasize the
need to use a second confirmation method on every ap-
parently positive product. Gel electrophoresis can quickly
eliminate products of vastly different size than expected,
but a second method is required. Sibley et al., [39] used
restriction fragment length polymorphism (RFLP) and
nested-PCR to confirm T. gondii DNA sequence in PCR
products. However, full sequencing provides a greater
amount of data than RFLP, potentially yielding data for
phylogenetic comparisons. Because of the ease and accur-
acy of DNA sequencing, it is recommended that similar
studies use this method to confirm T. gondii presence and
improve detection techniques.
Conclusions
The incidence of oocyst shedding in the cat population
studied was significantly higher than expected and
higher than found in most cat populations world-wide.
Further research should be conducted to determine if
the high prevalence of oocyst shedding cats is typical of
the area. If so, measures in public education of at-risk
groups may be warranted. Of broad importance, the
primers tested were shown to produce false positives at
a higher rate than true positives, emphasizing the need
for confirmatory DNA sequence analysis. Current
primers are tested against other common pathogens for
use in clinical detection, but not against the numerous
bacteria typically present in cat feces. Further research
may produce better protocols for Toxoplasma detection
from cat fecal samples.rior studies on Toxoplasma gondii oocysts in cat feces
%) Difference from current Significance (χ2 test) Reference
Less p = 0 [22]
Less p = 0 [20]
Less p = 0 [21]
Less p = 0 [18]
Less p = 0 [19]
Less p = 0 [33]
Less p = 0 [34]
Less p = 0.0001 [35]
Less p = 0.003 [27]
Less p = 0.008 [26]
Comparable p = 0.85 [28]
Comparable p = 0.06 [36]
More p = 0.007 [28]
detection using mouse bioassay.
ces.
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